A5029711573- Cardiac Valve Diseases and Treatments
- Aortic Disease and Treatment Approaches
- Infective Endocarditis Diagnosis and Management
- Cardiac and Coronary Surgery Techniques
- Cardiac, Anesthesia and Surgical Outcomes
- Congenital Heart Disease Studies
- Aortic aneurysm repair treatments
- Cardiac Structural Anomalies and Repair
- Peripheral Nerve Disorders
- Cardiac pacing and defibrillation studies
- Cardiac Imaging and Diagnostics
- Mechanical Circulatory Support Devices
- Coronary Interventions and Diagnostics
- Foreign Body Medical Cases
- Shoulder Injury and Treatment
- Infectious Aortic and Vascular Conditions
- Orthopedic Surgery and Rehabilitation
- Nerve Injury and Rehabilitation
- Blood transfusion and management
- Antiplatelet Therapy and Cardiovascular Diseases
- ECG Monitoring and Analysis
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Atherosclerosis and Cardiovascular Diseases
- Healthcare Technology and Patient Monitoring
- Vascular anomalies and interventions
Istituti di Ricovero e Cura a Carattere Scientifico
2021-2024
MultiMedica
2021-2024
Hospital Universitario de Móstoles
2021
Magna Graecia University
2020
Azienda Ospedaliera di Cosenza
2016-2020
Istituto Clinico Sant'Ambrogio
2020
Ospedale Sant'Anna
2006-2019
Hospital Universitario Puerta de Hierro Majadahonda
2019
Istituto Nazionale di Fisica Nucleare, Sezione di Lecce
2019
Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione
2019
Treatment pathway optimisation in TAVI should include timely patient discharge with a minimised risk for out-of-hospital adverse events. The aim of this study was to define standardised set criteria that allows safe and discharge, validate their appropriateness prospectively different centres multiple European countries, assess post-discharge outcomes.We defined validated the adequacy its ability predict properly after intervention prospective, European, multicentre registry. A total 502...
The impact of sutureless and rapid deployment (SURD) valves on the clinical outcomes patients undergoing minimally invasive aortic valve replacement (MI-AVR) has still to be defined. aim this study was assess characteristics in-hospital results receiving SURD-AVR through less approaches in large population Sutureless Rapid Deployment International Registry (SURD-IR).Of 1935 who received primary isolated between 2009 2018, a total 1418 (73.3%) underwent MI interventions were included...
The Sutureless and Rapid-Deployment Aortic Valve Replacement International Registry (SURD-IR) was established by a consortium of 18 research centres-the Valvular Surgery Study Group (IVSSG)-to overcome limitations the literature provide adequately powered evidence on sutureless rapid-deployment aortic valves replacement (SURD-AVR).Data from 3343 patients undergoing SURD-AVR over 10-year period (2007-2017) were collected in registry. mean age 76.8 ± 6.7 years, with 36.4% being 80 years or...
The aim of this multicentre study is to report the clinical experiences all patients undergoing transcatheter aortic valve implantation (TAVI) with a balloon-expandable device in Italy.The Italian Transcatheter balloon-Expandable Registry (ITER) real-world registry that includes who have undergone TAVI Sapien (Edwards Lifesciences, Irvine, CA, USA) bioprosthesis Italy since it became available practice. From 2007 2012, 1904 were enrolled undergo 33 centres. Outcomes classified according...
Benefits of sutureless and rapid deployment (SURD) bioprostheses in bicuspid aortic valves (BAV) are controversial. The aim this study is to report the outcomes patients undergoing valve replacement (AVR) for BAV from Sutureless Rapid-Deployment Aortic Valve Replacement International Registry (SURD-IR).Of 4,636 who received primary isolated SURD-AVR between 2007 2018, 191 (4.1%) underwent AVR with SURD valve.Overall 30-day mortality was 1.6%. Intuity implanted 53.9% cases, whereas Perceval...
The aim of this study was to assess the efficacy and safety Occlutech Paravalvular Leak Device (PLD) for percutaneous closure paravalvular leaks (PVL).Patients with PVL were enrolled at 21 sites from nine countries. Indications heart failure and/or haemolytic anaemia. Endpoint measures changes in PV regurgitation grade, NYHA class requirement haemolysis-related transfusion. One-hundred thirty-six patients mitral (67.6%) or aortic (32.4%) included (mean age 66.7 years, 58% male); 31% had...
Palpitation is a common symptom that sometimes results from substantial cardiac arrhythmia. We compared the diagnostic yield of trans-telephonic event monitors with those Holter monitoring in patients intermittent palpitations. In all, 310 were randomly assigned to receive an recorder or 24–hour monitoring. Event recorders used for seven days until two recordings obtained while symptoms occurred. The main end-point was electrocardiogram (ECG) recorded during symptoms. palpitation one-lead...
To correlate the ultrasound (US) measurements of median nerve cross-sectional area (CSA) and its stiffness by shear wave elastography (SWE) with severity grade carpal tunnel syndrome (CTS) using electrodiagnostic testing (EDT) to determine cutoff points for CSA SWE allow us discriminate patients moderate severe CTS from those mild or negative EDT findings.Seventy-three 105 hands a clinical suspicion were studied US SWE. We measured elasticity (E) at inlet (CSAu Eu), in quadratus pronator...
Current evidence on sutureless and rapid deployment aortic valve replacement (SURD-AVR) is limited does not allow for the assessment of clinical impact evolution procedural outcomes this new technology. The Sutureless Rapid Deployment International Registry (SURD-IR) represents a unique opportunity to evaluate current trends SURD-AVR interventions.Data from 3682 patients enrolled between 2007 2018 were analysed. Patients divided according date surgery into 6 equal groups by type...
There is an increasing trend towards shorter hospital stays after transcatheter aortic valve implantation (TAVI), in particular for patients undergoing the procedure via transfemoral (TF) access. Preliminary data suggest that there exists a population of can be discharged safely very early TF-TAVI. However, current evidence limited to few retrospective studies, encompassing relatively small sample sizes. The Feasibility And Safety discharge Transfemoral TAVI (FAST-TAVI) registry prospective...
Abstract OBJECTIVES The ideal strategy for the treatment of severe aortic valve stenosis in patients varying risk categories has become a debated topic last years: should transcatheter or surgical approach be adopted? aim this study was to evaluate outcomes low-, intermediate-, high- and very high-risk undergoing sutureless, rapid deployment replacement. METHODS From 2007 2017, data on total 3651 were collected from Sutureless Rapid Deployment Aortic Valve Replacement International Registry...
Abstract OBJECTIVES Minimally invasive surgical techniques with optimal outcomes are of paramount importance. Sutureless and rapid deployment aortic valves increasingly implanted via minimally approaches. We aimed to analyse the procedural a full sternotomy (FS) compared those cardiac surgery (MICS) further assess MICS, namely ministernotomy (MS) anterior right thoracotomy (ART). METHODS selected all isolated valve replacements in Rapid Deployment Aortic Valve Replacement International...
To assess the cost-effectiveness (CE) of transcatheter aortic valve implantation (TAVI) in Italy, considering patient groups with different surgical risk.A Markov model a 1-month cycle length, comprising eight health states, defined by New York Heart Association functional classes (NYHA I-IV), and without stroke plus death, was used to estimate CE TAVI for intermediate-, high-risk inoperable patients replacement or medical treatment as comparators according group. The Italian National Health...
Stroke incidence after transcatheter aortic valve implantation (TAVI) still represents a concern. This multicentre study aimed at investigating the hypothesis that CHADS2 and CHA2DS2-VASc scores may be used to predict perioperative stroke TAVI. The Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER) is multicentre, prospective registry of patients undergoing balloon-expandable TAVI using Edwards Sapien XT prosthesis between 2007 2012. primary end-point this was 30-day...
Background Despite the availability of guidelines for performance transcatheter aortic valve implantation (TAVI), current treatment pathways vary between countries and institutions, which impact on mean duration postprocedure hospitalization. Methods Results This was a prospective, multicenter registry 502 patients to validate appropriateness discharge timing after transfemoral TAVI, using prespecified risk criteria from FAST-TAVI (Feasibility Safety Early Discharge After Transfemoral [TF]...
To compare procedural and in-hospital outcomes of patients undergoing sutureless (Perceval, Livanova PLC, London, UK) rapid deployment (Intuity Elite, Edwards Lifesciences, Irvine, CA, USA) aortic valve replacement (group 1) versus sutured 2).Patients receiving isolated between 2014 2020 were analysed using data from the Sutureless Rapid Deployment International Registry. Patients in group 1 2 propensity-score matched a 1:1 ratio.A total 7708 included study. After matching, groups 2643 each...